Clinical Trials Directory

Trials / Completed

CompletedNCT05412654

Potassium Supplementation to Reduce Blood Pressure

Testing the Potential Effect of a Potassium-rich Water Intervention on Blood Pressure in Mild to Moderately Hypertensive Adults: a Double-blind Randomised Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Oxford Brookes University · Academic / Other
Sex
All
Age
20 Years – 64 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to conduct a definitive trial to assess the efficacy of consuming 1L/day of water rich in potassium to reduce blood pressure in mild to moderately hypertensive adults. The objective is to assess the potential effect of the intervention on reducing systolic blood pressure. This study will comprise of a 4 week, double-blind, parallel randomised controlled trial. Participants will be adults with systolic blood pressure measurements of 130mmHg or greater. The intervention comprises advice to consume bottled water rich in potassium. The comparator will be regular bottled mineral water.This study will recruit 40 people with elevated systolic blood pressure (≥130mmHg) who are not regularly taking antihypertensive medication.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHigh potassium waterHigh potassium water Potassium 6.2 mg/100ml
DIETARY_SUPPLEMENTControl low potassium waterControl water Potassium 0.2 mg/100ml

Timeline

Start date
2022-07-30
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2022-06-09
Last updated
2024-04-04

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05412654. Inclusion in this directory is not an endorsement.